The main goal of this study is to investigate how dihydrogen supplementation impacts body composition, appetite, quality of life specific to obesity, and levels of the hormone GLP-1 in men and women with obesity. This randomized controlled trial aims to explore whether dihydrogen can improve these health indicators.

The primary aim of this randomized controlled trial is to evaluate the effects of dihydrogen supplementation on body composition indices, appetite, obesity-specific quality of life, and circulating GLP-1 levels in obese men and women

Inclusion Criteria:

• Age 18-65 years
• Body fat > 30% in women and > 25% in men
• Not physically active
• Informed consent signed

Exclusion Criteria:

• Major chronic disease and acute injuries
• History of dietary supplement use during the past 4 weeks
• History of obesity pharmaceuticals use during the past 8 weeks
• No consent to randomization
• Participation in other studies

Data obtained through this study may be provided to qualified researchers with academic interest in obesity. Data will be coded, with no PHI included. Approval of the request and execution of all applicable agreements are prerequisites to the sharing of data with the requesting party.

Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.

Data obtained through this study may be provided to qualified researchers with academic interest in obesity.